Kaleo Release: Pharma Announces U.S. Availability And Pricing To Patients Of AUVI-Q (Epinephrine Injection, USP) Auto-Injector, For Life-Threatening Allergic Reactions Post author:Sam Post published:January 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Commonwealth Diagnostics Announces U.S. Launch And New Global Developments August 30, 2017 Cambridge's Semma Therapeutics Lands $114M for Novel Diabetes Quest November 29, 2017 Eli Lilly Gets Another Shot at FDA Approval for RA Drug March 14, 2018